| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V128076 | Ac-DMLD-CMK | 2588354-33-8 | Ac-DMLD-CMK is a caspase 3 inhibitor and a GSDME inhibitor. |
|
V128272 | Ac-VDVAD-CHO TFA | Ac-VDVAD-CHO TFA is a caspase-2/3 inhibitor (IC50: 46 and 15 nM). | |
|
V106281 | ATWLPPRAANLLMAAS | 1228447-26-4 | ATWLPPRAANLLMAAS is a chimeric peptide with anti-angiogenic and potent anti-tumor effects. |
|
V112049 | Boc-AEVD-CHO TFA | Boc-AEVD-CHO TFA is a caspase 8 inhibitor. | |
|
V131116 | Caspase-3-IN-3 | 1984421-81-9 | Caspase-3-IN-3 is a caspase 3 inhibitor. |
|
V131291 | CDK6-IN-2 | CDK6-IN-2 is a CDK6 covalent inhibitor with an IC50 value of 0.013 μM. | |
|
V67696 | Estrogen receptor modulator 10 | 2991504-90-4 | Estrogen receptor modulator 10 (compound G-5b) is an estrogen receptor (ER) antagonist (IC50=6.7 nM) and degrader (DC50=0.4 nM). |
|
V104867 | HDAC-IN-82 | HDAC-IN-82 (compound 18b) is a histone deacetylase (HDAC) inhibitor with selective anti-plasmodial and anti-cancer activities. | |
|
V137173 | HDAC1/6-IN-3 | 3038691-85-6 | HDAC1/6-IN-3 is a potent HDAC inhibitor. |
|
V120042 | IGN523 | IGN523 is an anti-CD98 antibody (hCD98, KD = 0.55 nM). | |
|
V23175 | KEA1-97 | 2138882-71-8 | KEA1-97 is a selective Thioredoxin-caspase 3 interaction interferer (IC50=10 μM). |
|
V140098 | MO-2097 | 2744300-63-6 | MO-2097 is a RAF-1/HIF-1α inhibitor. |
|
V0031 | Q-VD-OPh | 1135695-98-5 | Q-VD-OPh (also known asQVD-OPH; Quinoline-Val-Asp-Difluorophenoxymethylketone) is a novel, potent and irreversiblepan-caspase inhibitor with potential anticancer activities. |
|
V142679 | PI3K/mTOR-IN-17 | PI3K/mTOR-IN-17 is a dual PI3K and mTOR inhibitor with IC50 values of 1.21 μM (PI3K) and 0.21 μM (mTOR), respectively. | |
|
V142681 | PI3K/mTOR-IN-22 | PI3K/mTOR-IN-22 is an orally effective dual inhibitor of PI3K/mTOR kinases with IC50 values of 400.5 nM and 8.2 nM, respectively. | |
|
V144231 | RN-0001 | 252731-57-0 | RN-0001 is a cycloavidin (Cyp) inhibitor with Ki values of 4.1 nM and 12.0 nM for CypA and CypD, respectively, and an EC50 value of 916 nM for CypD. |
|
V144377 | RP-182 acetate | RP-182 acetate is a synthetic immunomodulatory peptide that exerts its antitumor effect by targeting the mannose receptor CD206 (Kd = 8 μM) on the surface of tumor-associated macrophages (TAMs). | |
|
V144661 | SBP-5147 | 1884222-37-0 | SBP-5147 is an orally effective ULK1/ULK2 inhibitor with an IC50 of 2 nM for ULK1 and 53 nM for ULK2. |
|
V145021 | SL-176 | 1809556-48-6 | SL-176 is a PPM1D (Wip1) inhibitor. |
|
V145067 | SMO-IN-6 | SMO-IN-6 is a smoothed (SMO) inhibitor with an IC50 value of 0.12 μM in humans. It has enhanced water solubility, good plasma and metabolic stability, moderate therapeutic index, preliminary safety profile, and moderate oral bioavailability in rats. |